Private investor briefing

RNS Number : 9719F

Diaceutics PLC

12 March 2020

 

Diaceutics PLC

("Diaceutics" or the "Company")

Private investor briefing

As previously announced on 27 February 2020, Diaceutics PLC (AIM: DXRX), the diagnostic commercialisation company, are due to hold a private investor event on Monday 16 March at the Copper Bar, Balls Brothers, 6 Adams Court, London EC2N 1DX.

This event will now take place as a video conference call facility.

If you would like the details of this call, please contact Walbrook PR on 020 7933 8780 or email   [e-mail] .

Enquiries:

Diaceutics PLC	www.diaceutics.com
Peter Keeling, Chief Executive Officer	via Walbrook PR
Philip White, Chief Financial Officer
Walbrook PR	Tel: [phone] or [e-mail]
Anna Dunphy		Mob: [phone]
Paul McManus		Mob: [phone]

About Diaceutics

Diaceutics PLC is the diagnostic commercialisation company for global pharmaceutical companies.  The Company, quoted on the Alternative Investment Market (AIM) of the London Stock Exchange, is enabling pharma to accelerate their market penetration and achieve a better return on precision medicine therapies by helping them to revolutionise patient testing.  By generating insights from its data lake of clinical laboratory testing data and other data, Diaceutics helps pharma understand and leverage the diagnostic landscape through initiatives that improve patient testing, leading to better treatment outcomes.  The Company works with more than 35 global pharmaceutical companies across hundreds of precision medicine projects. The Company employs a leading global group of experts from the laboratory, diagnostic and pharmaceutical industries.  www.diaceutics.com

 

END

 

 

NRAEALDAFAFEEFA